Edenred SA (EDEN)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 25.91 |
|---|---|
| 52-week range | 15.23 – 30.85 |
| Return, 1 month / 3 months | −6.4% / −0.9% |
| Return, 1 year / 3 years | +9.5% / −43.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 43.3% |
| Worst drawdown (1 year) | -41.0% |
| Average daily value traded | 13.73M EUR |
| Dividend yield | 5.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Edenred is a French company that provides payment and benefit solutions for employers, employees and merchants. Its services include meal vouchers, food cards, gift and incentive programmes, and fuel and maintenance cards for managing vehicle fleets. It also offers solutions for corporate payments and expense management. The company works with businesses of many kinds and with the restaurants, shops and service stations that accept its products, and it operates across numerous countries from its base in France.
Edenred SA trades under the code EDEN on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Edenred SA (EDEN) trades on the Euronext Paris in France. It last closed at EUR 25.91 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 64 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.5% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.4% | ||
| From 52-week high | -15.1% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -0.9% | ||
| 6-month return | 30.8% | ||
| 12-month return, skipping the last month | 17.0% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.0% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 13.73M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −13.8% |
|---|---|
| 1 month | −6.4% |
| 3 months | −0.9% |
| 6 months | +30.8% |
| 1 year | +9.5% |
| 3 years | −43.0% |
| 5 years | −37.2% |
Signals
| 50-day / 200-day average | 28.63 / 22.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jun 2026 | EUR 1.3300 |
| 10 Jun 2025 | EUR 1.2100 |
| 10 Jun 2024 | EUR 1.1000 |
| 7 Jun 2023 | EUR 1.0000 |
| 7 Jun 2022 | EUR 0.9000 |
| 14 May 2021 | EUR 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.